The rising interest in GLP-1 agonists for diabetes has led to a discussion about application forms : transdermal systems versus pills . Usually , GLP-1 therapies were solely available in pill form, but https://mariamvsne020058.blog5star.com/41323341/glp-1-transdermal-delivery-systems-vs-tablets-what-suitable-for-the-patient